TYR and melanoma: In 78 melanoma patients with resected regional lymph node metastases (NCT00940004, NCT01530698, NCT02285413, NCT00243529), vaccination with gp100- and tyrosinase-mRNA loaded DC vaccines as an adjuvant treatment showed a favorable safety profile and induced tumor-specific T-cell responses in 71% of the patients [63].